"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 52 | 52 |
| 1996 | 0 | 71 | 71 |
| 1997 | 0 | 65 | 65 |
| 1998 | 0 | 58 | 58 |
| 1999 | 0 | 49 | 49 |
| 2000 | 0 | 71 | 71 |
| 2001 | 0 | 71 | 71 |
| 2002 | 0 | 85 | 85 |
| 2003 | 0 | 93 | 93 |
| 2004 | 0 | 104 | 104 |
| 2005 | 0 | 120 | 120 |
| 2006 | 0 | 113 | 113 |
| 2007 | 0 | 138 | 138 |
| 2008 | 0 | 196 | 196 |
| 2009 | 0 | 164 | 164 |
| 2010 | 0 | 194 | 194 |
| 2011 | 0 | 233 | 233 |
| 2012 | 0 | 220 | 220 |
| 2013 | 0 | 243 | 243 |
| 2014 | 0 | 243 | 243 |
| 2015 | 0 | 267 | 267 |
| 2016 | 0 | 260 | 260 |
| 2017 | 0 | 244 | 244 |
| 2018 | 0 | 257 | 257 |
| 2019 | 0 | 269 | 269 |
| 2020 | 0 | 242 | 242 |
| 2021 | 0 | 189 | 189 |
| 2022 | 0 | 35 | 35 |
| 2023 | 0 | 36 | 36 |
| 2024 | 0 | 198 | 198 |
| 2025 | 0 | 16 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes. Blood. 2025 Mar 13; 145(11):1126-1135.
-
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis. Blood Adv. 2025 Mar 11; 9(5):1232-1241.
-
Locus coeruleus tau validates and informs high-resolution MRI in aging and at earliest Alzheimer's pathology stages. Acta Neuropathol Commun. 2025 Feb 28; 13(1):44.
-
Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study. Cancer. 2025 Feb 15; 131(4):e35750.
-
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia. Blood. 2025 Feb 06; 145(6):577-589.
-
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1=50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry. J Immunother Cancer. 2025 Feb 04; 13(2).
-
Socioeconomic and Geographic Differences in Mammography Trends Following the 2009 USPSTF Policy Update. JAMA Netw Open. 2025 Feb 03; 8(2):e2458141.
-
A comparison of MRI and intraoperative measurements to determine interspinous spacer device size. Pain Pract. 2025 Feb; 25(2):e70001.
-
MRI-assessed Dynamic Hyperinflation Induced by Tachypnea in Chronic Obstructive Pulmonary Disease: The SPIROMICS-HF Study. Radiol Cardiothorac Imaging. 2025 Feb; 7(1):e240053.
-
Real-world application of CCTA with CT-FFR for coronary assessment pre-TAVI: the CT2TAVI study. Int J Cardiovasc Imaging. 2025 Mar; 41(3):523-535.